Basic Information
OverT Bio is developing effective and safe cellular therapies for solid tumors. Founded in 2022 by Dr. Mat Legut and Dr. Neville Sanjana, OverT Bio pioneered a novel pooled functional screening and synthetic genomics platform to develop next-generation engineered immune cells.
OverT Bio, Inc.
NewYork,NewYork,United States of America
less than 15 people
--
contact@overt.bio